here, we review current literature regarding the incidence of cancer therapy induced insulin resistance and describe the systemic and extra and intracellular changes that occur in insulin signalling pathways and glucose metabolism. subsequently clinical and preclinical evidence for consequences of insulin resistance in terms of cancer progression and survival is presented.